Tag Archives: comparative effectiveness

Interesting article in the online Financial Times yesterday which describes the ongoing debate over off-label usage of Avastin(R) in lieu of the much more expensive Lucentis(R) for treatement of wet AMD.  Over the recommendation of their own specialist ophthalmic association! … Continue reading →